Duopharma Biotech Berhad (7148.KL)

MYR 1.24

(-0.8%)

Annual Balance Sheets

(In MYR)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 1.34 Billion 1.22 Billion 1.16 Billion 1.05 Billion 919.8 Million 836.37 Million
Total Current Assets 677.06 Million 541.48 Million 494.79 Million 459.69 Million 417.2 Million 367.33 Million
Cash And Short Term Investments 270.5 Million 157.63 Million 137.98 Million 158.02 Million 120.66 Million 98.25 Million
Cash and Cash Equivalents 270.5 Million 157.63 Million 137.98 Million 158.02 Million 120.66 Million 98.25 Million
Short Term Investments 161.79 Million -1.05 Million -1.05 Million -1.1 Million -1.2 Million -1.2 Million
Net Receivables 161.41 Million 142.15 Million 132.72 Million 124.77 Million 130.78 Million 122.48 Million
Inventory 243.06 Million 235.17 Million 222.19 Million 151.26 Million 144 Million 139.6 Million
Other Current Assets 2.07 Million 6.51 Million 1.9 Million 25.62 Million 21.74 Million 129.46 Million
Total Non-Current Assets 668.06 Million 680.43 Million 669.33 Million 598.73 Million 502.59 Million 469.04 Million
Net PPE 582.36 Million 579.91 Million 542.52 Million 441.78 Million 412.24 Million 386.18 Million
Good Will And Intangible Assets 38.8 Million 43.98 Million 39.52 Million 35.06 Million 28.11 Million 19.4 Million
Good Will - - - - - -
Intangible Assets 38.8 Million 43.98 Million 39.52 Million 35.06 Million 28.11 Million 19.4 Million
Long-Term Investments 37.95 Million 43.2 Million 74.58 Million 113.34 Million 53.03 Million 53.26 Million
Tax Assets 8.94 Million 13.33 Million 12.7 Million 8.53 Million 9.19 Million 10.2 Million
Other Non Current Assets -1.00 - - - - -
Other Assets 1.00 - - - - -
Total Liabilities 658.01 Million 566.69 Million 540.12 Million 414.61 Million 390.05 Million 355.33 Million
Total Current Liabilities 166.72 Million 264.59 Million 230.3 Million 150.32 Million 239.44 Million 222.44 Million
Account Payables 40.45 Million 51.92 Million 31.32 Million 22.93 Million 34.67 Million 31.2 Million
Tax Payables 367 Thousand 1.16 Million 6.05 Million 744 Thousand 652 Thousand 321 Thousand
Short Term Debt 66.47 Million 135.08 Million 103.56 Million 49.39 Million 125.44 Million 121.84 Million
Deferred Revenue 367 Thousand - - - - 321 Thousand
Other Current Liabilities 59.43 Million 77.58 Million 95.42 Million 77.99 Million 79.33 Million 69.08 Million
Total Non Current Liabilities 491.28 Million 302.1 Million 309.81 Million 264.29 Million 150.6 Million 132.89 Million
Long-Term Debt 480.9 Million 296.52 Million 300.27 Million 253.94 Million 140.55 Million 121.65 Million
Deferred Revenue Non Current -1.00 - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.47 Million - - - - -
Other Liabilities 1.00 - - - - -
Total Equity 687.12 Million 655.22 Million 624 Million 643.82 Million 529.75 Million 481.04 Million
Stock Holders Equity 687.12 Million 655.22 Million 624 Million 643.82 Million 529.75 Million 481.04 Million
Common Stock 432.46 Million 419.36 Million 405.85 Million 404.92 Million 374.4 Million 347.18 Million
Retained Earnings 319.06 Million 288.37 Million 239.97 Million 220.18 Million 182.94 Million 161.07 Million
Accumulated other comprehensive income -64.4 Million -52.51 Million -21.82 Million 18.71 Million -27.6 Million -27.22 Million
Common Stock Equity 687.12 Million 655.22 Million 624 Million 643.82 Million 529.75 Million 481.04 Million
Capital Lease Obligation 1.47 Million 2.86 Million 3.11 Million 1.26 Million 1.59 Million -
Total Investments 37.95 Million 42.15 Million 73.53 Million 112.24 Million 51.83 Million 52.06 Million
Total Debt 548.84 Million 431.6 Million 403.84 Million 303.33 Million 265.99 Million 243.49 Million
Net Debt 278.34 Million 273.96 Million 265.86 Million 145.3 Million 145.32 Million 145.23 Million

Balance Sheet Charts